Key facts
- This page summarizes Michael D. Loberg's Form 4 filing for IGM Biosciences, Inc. (IGMS).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 03 Oct 2023, 19:51.
Michael D. Loberg - 29 Sep 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)
- Reporting relationship
- Director
- Issuer ticker
- IGMS
- Reported as of
- 29 Sep 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Oct 2023, 19:51:34 UTC
- Prior SEC filing
- 05 Jul 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Misbah Tahir, by power of attorney
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Michael D. Loberg filed Form 4 for IGM Biosciences, Inc. (IGMS) on 03 Oct 2023.
Change
- Previous filing in this sequence was filed on 05 Jul 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IGMS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,138
- Change %
- Price
- $0.000000
- Shares after
- 1,138
- Date
- 29 Sep 2023
- Ownership
- Direct
- Footnotes
- F1, F2
IGMS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 47,983
- Date
- 29 Sep 2023
- Ownership
- See footnote
- Footnotes
- F2, F3
IGMS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 33,807
- Date
- 29 Sep 2023
- Ownership
- See footnote
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
Michael D. Loberg is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 4 footnotes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. The amount reflects payment of a quarterly retainer in common stock pursuant to the Issuer's Outside Director Compensation Policy.
Footnote F2
The number of shares held reflects the transfer on August 15, 2023 of 1,138 shares from the Reporting Person to Revocable Deed of Trust of Michael D. Loberg (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees (the "Revocable Deed of Trust").
Footnote F3
The shares are held by the Revocable Deed of Trust.
Footnote F4
The shares are held by the Michael D. Loberg Qualified Annuity Interest Trust IX (Michael and Melinda Loberg, Trustees), of which Reporting Person and his spouse serve as trustees.